Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) potential merits of including ME/CFS on the list of neurological conditions in group 6 of the JCVI priority list and (b) consistency of GP decisions on including ME/CFS patients in group 6.

The Joint Committee on Vaccination and Immunisation has not identified any robust data to indicate that, as a group, persons with myalgic encephalomyelitis/chronic fatigue syndrome are at higher risk of dying from COVID-19, therefore this group is not included as part of the prioritisation for phase one of the programme.